Hendrickson M, Myre L, Johnson D G, Matlak M E, Black R E, Sullivan J J
Primary Children's Medical Center, University of Utah Health Sciences Center, Salt Lake City 84103.
J Pediatr Surg. 1990 Feb;25(2):185-90; discussion 190-1. doi: 10.1016/0022-3468(90)90400-4.
Few advancements in postoperative pain control in children have been made despite longstanding inadequacies in conventional intramuscular analgesic regimens. While overestimating narcotic complication rates, physicians often underestimate efficacious doses, nurses are reluctant to give injections, and many children in pain shy away from shots. This study prospectively focuses on the safety, efficacy, and complication rate of intermittent intramuscular (IM) versus continuous intravenous infusion (IV) of morphine sulfate (MS) in 46 nonventilated children following major chest, abdominal, or orthopedic surgical procedures. Twenty patients assigned to the IM group had a mean age of 6.17 years and a mean weight of 23.0 kg. Twenty-six patients assigned to the IV group had a mean age of 8.74 years and a mean weight of 27.4 kg. The mean IM MS dose was 12.3 micrograms/kg/h while the mean IV dose was 19.8 micrograms/kg/h (P less than .001). Postoperative pain was assessed with a linear analogue scale from 1 to 10 (1, "doesn't hurt"; 10, "worst hurt possible") for 3 days following operation. Using the analysis of covariance (ANACOVA), nurse, parent, and patient mean pain scores in the IV group were significantly lower than those of the IM group when controlled for age, MS dose, and complications (P less than .007). Nurse assessment of pain correlated well with the patient and parent assessments (Pearson correlation coefficients greater than 0.6). Not only did IV infusion give better pain relief than IM injections, but there were no major complications such as respiratory depression. Minor complications in this study (nausea, urinary retention, drowsiness, vomiting, hallucinations, lightheadedness, and prolonged ileus) were not significantly different between IM and IV groups.(ABSTRACT TRUNCATED AT 250 WORDS)
尽管传统的肌内注射镇痛方案长期存在不足,但儿童术后疼痛控制方面的进展却很少。医生在高估麻醉并发症发生率的同时,往往低估有效剂量,护士不愿进行注射,而且许多疼痛的儿童害怕打针。本研究前瞻性地关注了46名接受胸、腹或骨科大手术后未通气儿童,间歇肌内注射(IM)与持续静脉输注(IV)硫酸吗啡(MS)的安全性、有效性和并发症发生率。分配到IM组的20名患者平均年龄为6.17岁,平均体重为23.0千克。分配到IV组的26名患者平均年龄为8.74岁,平均体重为27.4千克。IM组MS的平均剂量为12.3微克/千克/小时,而IV组的平均剂量为19.8微克/千克/小时(P小于0.001)。术后3天,使用1至10的线性模拟量表(1表示“不痛”;10表示“可能的最痛”)评估疼痛程度。使用协方差分析(ANACOVA),在控制年龄、MS剂量和并发症后,IV组护士、家长和患者的平均疼痛评分显著低于IM组(P小于0.007)。护士对疼痛的评估与患者和家长的评估相关性良好(Pearson相关系数大于0.6)。静脉输注不仅比肌内注射能更好地缓解疼痛,而且没有呼吸抑制等主要并发症。本研究中的轻微并发症(恶心、尿潴留、嗜睡、呕吐、幻觉、头晕和肠梗阻延长)在IM组和IV组之间没有显著差异。(摘要截断于250字)